|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Psoriasis | |||||
| Eczema | |||||
| 2 | More general conditions related to this trial | ||||
| Dermatitis | |||||
| Skin Diseases | |||||
| Skin Diseases, Eczematous | |||||
| Skin Diseases, Papulosquamous | |||||
| 3 | Interventions listed in this trial | ||||
| Neuroskin Forte | |||||
| Placebo Application | |||||
| 4 | Sponsors listed in this trial | ||||
| University of Medicine and Dentistry New Jersey | |||||
| AVVAA World Healthcare Products, Inc. | |||||